3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other neoplasm
1
Gynecologic
1
Conditions
Uterine Cervical Neoplasms
17
Uterine Cervical Dysplasia
10
Papillomavirus Infections
6
Precancerous Conditions
3
Neoplasms
3
Squamous Intraepithelial Lesions
2
Genital Diseases
2
Atypical Squamous Cells of the Cervix
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Uterine Diseases
1
Uterine Cervical Diseases
1
Urogenital Neoplasms
1
Urogenital Diseases
1
Sexually Transmitted Diseases, Viral
1
Sexually Transmitted Diseases
1
Neoplasms by Site
1
HIV Infections
1
Genital Neoplasms, Female
1
Genital Diseases, Female
1
Female Urogenital Diseases and Pregnancy Complications
1
Cervical Intraepithelial Neoplasia Grade 1 (CIN 1)
1
Adenocarcinoma in Situ
1
Interventions
Watchful Waiting
1
Transurethral Resection of Prostate
1
Telescopes
1
Radiotherapy, Intensity-Modulated
1
Radiosurgery
1
Pregnancy Tests
1
Nimorazole
1
Methods
1
Human Papillomavirus DNA Tests
1
Educational Status
1
Colposcopy
1
Cisplatin
1
Cholecalciferol
1
Biopsy, Needle
1
Biopsy
1
Acetic Acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Neoplasms by Site
×
Colposcopy
×
Clear all
NCT06815939
2026-01-29
OPTICS
DL Analytics
Phase NA
Recruiting
10,000 enrolled